People are turning to drugs like Ozempic and Wegovy to lose weight – but where do they fit in the body-positivity movement? Today on Post Reports, what some fat activists think of these drugs and how one doctor is talking about these medicines with her patients.

Read more:

Some companies are marketing GLP-1 drugs to body-positive influencers in the hopes that they’ll market their products to their followers.

Shane O’Neill is a style reporter at the Post and writes the Style Memo newsletter. When he heard about this marketing push, he reached out to some of these influencers and activists to get their take on whether these drugs had a place in their messaging.

At the same time, many doctors are busy fielding questions from patients who are interested in taking these drugs to lose weight. Mara Gordon is a physician in New Jersey who is trying to stop weight stigma by practicing a size-inclusive approach to medicine – meaning she doesn’t offer these drugs for weight loss. She doesn’t think that these drugs can cure fatphobia, and so she tries to talk through patients' goals with them and orient the solutions away from weight loss.

“So let's say I have a patient who doesn't have diabetes, but they say they want to lose weight. So we try to explore that – what are you hoping to achieve? What feels wrong in your life that feels related to, related to your body size?”

Today’s show was produced by Sabby Robinson. It was edited by Lucy Perkins and mixed by Sean Carter. Thanks to Monica Campbell and Ariel Plotnick.

Subscribe to The Washington Post here.

Como a GoodStorage está resolvendo um problema crônico das grandes cidades brasileiras - Café com ADM 469